The objective of this work was to evaluate any variation of renal function detected by renal scintigraphy after the suprarenal fixation of endografts for abdominal aortic aneurysm (AAA) repair. Summary Background Data: In the few articles that have considered this problem, renal function was evaluated only by biochemical tests, which are inadequate in demonstrating small changes in renal function and in appreciating the worsening of a single kidney's function. Methods: Between April 1999 and May 2002, 47 patients with an inappropriate infrarenal proximal neck had a suprarenal fixation for AAA. To assess renal function, a technetium-99m diethylene triamine penta-acetic acid ( 99m TC-DTPA) perfusion scintigraphy was performed preoperatively on the third postoperative day and at 6, 12 months, and then yearly thereafter. Worsening of renal function was defined as a decrease of glomerular filtration rate (GFR) Ն20% (detected with Gates method). Serum creatinine level was tested preoperatively and at the first and third postoperative day. Results: Endograft deployment was technically successful in 44 patients (93.6%); clinical perioperative success was obtained in 46 patients (97.8%). In 12 patients (25.5%), a permanent reduction of the GFR was observed using postoperative 99m TC-DTPA perfusion scintigraphy. By 99m TC-DTPA perfusion scintigraphy, a permanent reduction of GFR was observed postoperatively in 12 patients. A slight GFR reduction (Ͻ20%) was present in 7 (14.9%) patients, due to the planned occlusion of accessory renal arteries. A more significant GFR reduction (Ͼ20%) was present unexpectedly in 5 (10.6%) patients, in 3 of these a single kidney was involved, in 5 both with an increase of the serum creatinine level Ͼ20%.
Objective:
The objective of this work was to evaluate any variation of renal function detected by renal scintigraphy after the suprarenal fixation of endografts for abdominal aortic aneurysm (AAA) repair. Summary Background Data: In the few articles that have considered this problem, renal function was evaluated only by biochemical tests, which are inadequate in demonstrating small changes in renal function and in appreciating the worsening of a single kidney's function. Methods: Between April 1999 and May 2002, 47 patients with an inappropriate infrarenal proximal neck had a suprarenal fixation for AAA. To assess renal function, a technetium-99m diethylene triamine penta-acetic acid ( 99m TC-DTPA) perfusion scintigraphy was performed preoperatively on the third postoperative day and at 6, 12 months, and then yearly thereafter. Worsening of renal function was defined as a decrease of glomerular filtration rate (GFR) Ն20% (detected with Gates method). Serum creatinine level was tested preoperatively and at the first and third postoperative day. Results: Endograft deployment was technically successful in 44 patients (93.6%); clinical perioperative success was obtained in 46 patients (97.8%). In 12 patients (25.5%), a permanent reduction of the GFR was observed using postoperative 99m TC-DTPA perfusion scintigraphy. By 99m TC-DTPA perfusion scintigraphy, a permanent reduction of GFR was observed postoperatively in 12 patients. A slight GFR reduction (Ͻ20%) was present in 7 (14.9%) patients, due to the planned occlusion of accessory renal arteries. A more significant GFR reduction (Ͼ20%) was present unexpectedly in 5 (10.6%) patients, in 3 of these a single kidney was involved, in 5 both with an increase of the serum creatinine level Ͼ20%.
Conclusions: Suprarenal fixation of endografts in AAA treatment is a safe procedure with good early and midterm procedural results and a risk of GFR impairment (Ͼ20%) of 10.6%. (Ann Surg 2004; 240: 169 -178) O pen repair of abdominal aortic aneurysms (AAAs) in patients who are fit for invasive abdominal surgery is the established treatment of the prevention of rupture of large AAAs. It has now been shown to be technically feasible to repair AAAs endovascularly by the deployment of a graft within the aneurysm via a remote site. The continuous and rapid improvement in technology of aortic endografts make the available data on late results concerning old devices of no interest; by contrast, the early and midterm results regarding new devices are now encouraging. [1] [2] [3] [4] [5] [6] [7] This method could potentially be used in patients who are deemed unfit for conventional open repair, but recently there has been a tendency to use endovascular surgery in every patient with an aortic aneurysm who is morphologically suitable for the procedure. 8 The potential advantages of endovascular AAA repair have been discussed at length and include decreased morbidity, mortality, and length of stay, and a lower overall treatment cost. 9 However, not all AAAs are amenable to endovascular repair. Anatomic features of the infrarenal neck such, as severe angulations (Ͻ120°), pyramidal shape, short (Ͻ1.5 cm) distance between renal arteries and aortic aneurysm, and the presence of thrombus or heavy calcification may preclude endovascular repair with current infrarenal available devices because of an increase risk of type I endoleak and/or device migration. 10 -13 Moreover, the pararenal segment of the aorta frequently is preserved in these patients, even in the presence of a difficult infrarenal neck. Aneurysmal dilatation of this segment occurs less frequently with time, in contrast to that of the more distal infrarenal aorta. 14 -18 In these situations, where the risky condition of the patient increases operative mortality with traditional surgery, the only option for an endovascular treatment is suprarenal fixation (SF) of the endograft.
Fixation of the endovascular graft in the more stable suprarenal segment of the aorta has been demonstrated to reduce the incidence of proximal endoleak in patients with complex infrarenal aortic morphology. The safety and efficacy of the transrenally placed uncovered stent has been reported. Until now little has been reported about the results and consequence of SF of the endograft on renal function. 19 -27 Moreover in the few articles that considered this problem, renal function was evaluated only by serum creatinine level (SCL) or creatinine clearance which, as wellknown, are inadequate to demonstrate small changes in renal function and to appreciate worsening of function of a single kidney. 28 -30 The best way to evaluate renal function is to perform a direct measurement of glomerular filtration rate (GFR) by renography, which shows the function of each kidney. 28 The aim of this study is to evaluate any variation of GFR detect by renal scintigraphy after suprarenal fixation of endograft.
PATIENTS AND METHODS
Between April 1999 and May 2002, 381 patients have been operated for infrarenal AAA at the Division of Vascular Surgery of the University of Padova, Italy; among these, 135 (35.4%) underwent an endovascular repair and 47 (34.8%) had a SF.
All patients selected for endovascular repair were at high perioperative risk for open surgery (American Society of Anesthesiologists class III-IV; Table 1 and 2). The aneurysm diameter ranged from 4.9 to 8.9 cm (mean, 5.8 cm) and 39 (82.9%) patients had aortic aneurysm diameter Ն 5.5cm. Indications for SF in AAA include: a short (Ͻ1.5 cm, ranging from 0.8 to1.5 cm) infrarenal proximal neck in 28 patients (59.5%), an angulation Ͻ120°between the flow axis of the proximal neck and the body of the aneurysm or a pyramidalshaped proximal neck in 11 patients (23.4%), and for the presence of iuxtarenal heavy (Ͼ50% of the circumference) calcification or thrombus in 8 patients (17.1%). Preoperative protocol includes blood pressure measurement, blood tests (with serum creatinine), angio-computed tomography (CT) scan (with measurement of kidney's diameters) and digital subtraction angiography (DSA) with measuring catheter, including lateral projection of the abdominal aorta. The angio-CT scan showed that a complete circumferential thrombus apposition on the aneurysm wall was present in 40 patients (85.1%).
To assess renal function, a perfusion scintigraphy was performed using a technetium-99m diethylene triamine penta-acetic acid (RPS 99m TC-DTPA); GFR was estimated with the Gates method.
Decisions regarding management of identified accessory renal arteries were made during preoperative planning. Consideration for excluding accessory renal arteries was based on the likelihood of inadequate sealing without coverage of the aberrant vessel(s). Only accessory vessels vascularizing less than 25% of the kidney, assessed at the preoperative angiographic and angio-CT scan were considered for coverage. Patients with an elevated serum creatinine level of Ͼ181 mol/L were rarely considered for endovascular grafting with accessory renal artery coverage. Patients were informed preoperatively of the need to cover these vessels to achieve a successful endovascular exclusion. The potential risks for renal parenchymal loss and consequent worsening of renal insufficiency (RI) and hypertension were addressed with patients, and their consents were obtained.
The endovascular procedure was always performed in the operating room under general or peridural anesthesia (12-inch digital C-arm fluoroscopy units Series Eurocolumbus, was used), and DSA was performed after the device deployment to identify any endoleaks and assess the patency of renal arteries covered by the bare stent. The contrast dye was usually 150 mL (range, 100 -160; Omnipaque-350). In patients with preoperative diagnosis of RI or with a SCL higher than 124 mol/L to favor the urine output of the iodine media, 1 L of glucoses solution at 5% and 50 mg/die of furosemide were infused in the first 2 postoperative days. The device used in the first period was a Talent (T) bifurcated endograft (World Medical, Sunrise, FL) in 14 patients (29.8%). Then, because of temporary commercial difficulties in our country obtaining this device, a Zenith (Z) bifurcated endograft (Cook, Inc, Bloomington, IN) was deployed in 33 patients (70.2%).
Devices
The Talent-LPS aortic stent-graft was a modular system composed of a nitinol wire frame supporting a thin-walled polyester graft. Proximal aortic fixation was achieved in the suprarenal aortic segment by using a 15-mm length of uncovered self-expanding nitinol stent. The stents are spaced along a full-length nitinol spine. The latter provides longitudinal (column) strength to a graft that is otherwise flexible to accommodate aorto-iliac angulations. The delivery system is composed of a coaxial sheath with an internal pusher rod and a compliant polyurethane balloon that is sequentially inflated to maximize apposition of the graft to the vessel wall target zones and to ensure full expansion of the device along its length. The basic components of the Talent AAA system are a bifurcated main section and a contralateral iliac limb. Available configurations include the Free-Flo graft with a 15-mm long uncovered stent at the proximal end to allow for suprarenal fixation. Additional modular components include aortic cuffs and iliac extensions. The manufacturer offers customization in a variety of configurations and sizes (length and diameters). Diameter ranges are 16 to 36 mm for the aortic section and 8 to 22 mm for the iliac limbs. 31 The Zenith endograft has evolved from a worldwide collaborative effort that began in 1991. Observations of early complications associated with endovascular grafting have resulted in a series of modifications that led to the current system. Initial studies in animals and humans used prostheses fashioned with Gianturco Z-stents and Dacron fabric. The implantable portion of this device has progressed from an unsupported monoiliac device to a fully supported modular bifurcated system. The current delivery system has undergone development in parallel to the prosthesis. Sophisticated mechanisms allow for fine positioning adjustments and the controlled release of a series of suprarenal barbs designed to mimic a surgical anastomosis. The endovascular system has incorporated many modifications to prevent failures that can be detected during early experiences. The device is now commercially available in Europe and Australia, and a phase II Food and Drug Administration trial is under way in the United States. Fixation site prosthesis diameters were chosen to be 15% larger than the outer wall-to-outer wall measurement of the cross-sectional image of the targeted segment. 32 Oversizing was performed in an effort to overcome the potential errors in measurement, to accommodate from slight expected aortic growth, and to allow the stents to expand to the adventitial layer of the artery. The prosthesis length was determined from CT scan reconstructions, axial images and calibrated angiography.
Procedural success was defined according to the reporting standards for endovascular repair. 33 The postoperative follow-up was based on blood pressure measurements every day until discharge (usually in the 4th postoperative day) and blood tests performed on the first and third postoperative days. In patients with worsening of global renal function, defined as SCL increased Ն20% above baseline, serum creatinine was tested up to the fifth, seventh postoperative day, and than weekly until stabilization was achieved. RPS 99m TC-DTPA was performed in third postoperative day and repeated at 1 month in patients with worsening of renal function, defined as a decrease of GFR Ն20%. Angio-CT was performed after 30 days from the procedure only in case of type II endoleak revealed by the DSA performed at the end of the device deployment.
The midterm follow-up included blood tests (with serum creatinine) at 3, 6, 12, 18, 24 months, and then yearly and RPS 99m TC-DTPA and angio-CT at 6, 12, months and then yearly. The position of the endograft was checked by plain abdominal radiography on the third postoperative day, at 6 and 12 months, and then yearly.
RESULTS

Procedural Results
Endograft deployment was technically successful in 44 patients (93.6%), 13/14 (92.8%; T), and 31/33 (93.9%; Z) ( Fig. 1 ). One case (Z), required a femoro-femoral crossover for branch occlusion, and in 2 cases (1T and 1Z) intraoperative DSA revealed a type II endoleak from lumbar arteries. These 2 cases were conservatively managed, stopping antiplatelet therapy in one case and anticoagulation in the second, and an angio-CT scan performed after 30 days showed the absence of the endoleak.
Clinical perioperative success was obtained in 46 patients (97.8%), 100% with Talent endograft and 96.9% with Zenith endograft (1 case of branch occlusion). In 1 patient a tight stenosis of the left renal artery required an angioplasty ϩ stent performed immediately after the endograft deployment. No device migration or type I endoleak were observed. There were no perioperative deaths.
The size of the body endograft implanted ranged from 25 to 32 mm for the aortic section and from 10 to 20 mm for the iliac limbs; the oversizing of the body was 25% (range, 15-40%). In 3 cases (6.3%) of aneurysm with a conical infrarenal neck ( Fig. 1 ) it was decided to do an oversizing of the endograft's body of 40% to guarantee the sealing even in the first portion (0.8 cm) of the infrarenal neck. Twenty-eight (59.6%) procedures were performed under general anesthesia. Eight (Z) patients suffered back pain for 2-5 days after the procedure.
During the follow-up period (1-36 months; mean, 16 months), one possible-risk patient candidate for heart transplantation died 8 months after the procedure of heart failure. Technical success was maintained in 43 patients (91.4%) and clinical success in 45 patients (95.7%): one patient had a branch occlusion of a Talent endograft 45 days after the procedure and required a femoro-femoral crossover. No type I-II-III or IV endoleak and graft migration were observed during the follow-up period by angio-CT scan and plain radiographs ( Table 3 ).
The angio-CT scan performed at 6 months in 24 patients (51.1%) showed an extension of the bare springs well above renal arteries. In 18 (75%) cases, the stent graft fixation was across the ostium of the superior mesenteric artery and in 5 (25%), an involvement of the celiac artery origin was observed without any complication on visceral perfusion (Fig. 2 ).
Renal Function
In 5 patients (10.6%) with preoperative RI, an impairment of global renal function (SCL Ͼ 20%) was observed in (Table 4 ). In 15 patients (31.9%; 2T-13Z) a change between the pre-and postoperative RPS 99m TC-DTPA was observed that was permanent in 12 (2T, 10Z) and transient in 3 (3Z) cases ( Table 4 ). The permanent change at RPS 99m TC-DTPA were expected in 7 patients and unexpected in 5. The expected changes were secondary to a planned segmentary renal infarction (Ͻ25% of total renal parenchyma) caused by the exclusion, after the device deployment, of a renal polar artery in 6 patients and of the isthmic arteries in a patient presenting a horseshoe kidney. In these patients no worsening of global renal function was observed (SCL remain stable and decrease of the GFR a the RPS 99m TC-DTPA was Ͻ20%). Unexpected changes were observed in 5 patients (10.6%; 1T-4Z) at the RPS 99m TC-DTPA performed on the third postoperative day; 3 (1T-2Z) of these patients had a preoperative RI.
In 2 of the patients with preoperative RI, the SCL continuously increased after the procedure until the seventh postoperative day and thereafter remained stable at values greater (Ͼ20%) than base line ( Table 5 ). The postoperative RPS 99m TC-DTPA showed a significant decrease of GFR involving, in one case, both kidneys and in the second only the right kidney (Table 5 ). In this last patient, blood pressure rose during the postoperative period and it was necessary to increase medications to control the hypertension. The third Table 5 ). The RPS 99m TC-DTPA performed during the follow-up (1 month in 2 cases and at 6 months and then at 1 year in the other) remained unchanged. In all cases the angio-CT scan demonstrated the patency of renal arteries and did not show the presence of renal infarction. In the other 2 (2Z) patients, with normal preoperative renal function, the postoperative RPS 99m TC-DTPA showed a significant decrease of GFR involving a single kidney in absence of significant change (Ͻ20%) of serum creatinine level ( Table 5 , Fig. 3 ).
These changes remain even at the RPS 99m TC-DTPA, performed during a follow-up period of 6 months in one patient and of 12 months in the other one. In both patients the angio-CT scan demonstrated the patency of the renal arteries and the absence of renal infarct. A static renal scintigraphy using 99m TC-DTPA was performed and did not reveal the presence of area of infarction in the impaired kidney.
In 6 (41.6%) of the 13 patients with preoperative RI, an impairment of renal function was observed that was permanent in the 3 (23.3%) cases previous described and transient in 3 (23.0%; 3Z).
In these 3 patients SCL increased reaching the higher value (Ͼ20% to base line) in the third postoperative day, then continuously decreased to return to base line level within the seventh postoperative day. In these patients the worsening of GFR (Ͼ20%) at the RPS 99m TC-DTPA, performed in the third postoperative day, involved both kidneys, then returned to preoperative level at 1 month control. One of these patients required 3 cycles of dialysis. Median systolic and diastolic pressure both were identical before and after endovascular repair except in one patient, who required intensification of antihypertensive therapy.
DISCUSSION
Endovascular repair for AAAs is a safe method with good early and midterm results in the treatment of patients at high perioperative risk for open surgery. [1] [2] [3] [4] [5] [6] [7] Nevertheless, a remarkable rate of patients (30 -40%) are not eligible for endovascular repair because of problems caused by the morphology of the proximal neck. 34 It's well established, in fact, that the proximal infrarenal neck morphology must have precise characteristics to be suitable to endovascular fixation: it has to be a thrombus or plaque-free segment of the aorta of at least 15 mm of length, the angle between the flow axis of the neck and the body of the aneurysm has to be Ͼ120°, and it must not have a pyramidal shape. According to many authors, infrarenal endografting is contraindicated in patients without this neck morphology for the high incidence of type I endoleak or device migration. 10 -13 The pararenal segment of the aorta usually is preserved in this cases. To permit the inclusion of this subpopulation of patients between cases amenable to endovascular repair, a suprarenal uncovered stent-graft fixation has been performed by several authors and reported a safety and efficacy procedure. 20 -27 There is also considerable evidence that infrarenal aorta may enlarge with time, leading to potential infrarenal device migration; even after conventional open repair of AAA, the proximal portion of the infrarenal aorta (between the lowest renal artery and the aortic graft) can continue to dilate, probably as part of the continuing aneurysmal disease. Such continued dilatation of the proximal neck could potentially be disastrous after endovascular repair because the proximal end of an endovascular graft is matched accurately to the proximal neck diameter as measured before surgery, usually oversized 10% to 20% to accommodate small measurement errors and to increase radial force, with the aim of achieving a permanent seal and anchorage. If there were to be continued dilatation of the proximal neck after EVR, the neck diameter increase would result in a loose fit. Thus, the stent graft could migrate distally and an endoleak around the top of the graft could result, with the consequent risk of rupture of the AAA. Moreover, suprarenal segment of the aorta seems to be more stable respect the infrarenal one with a lower increase of his diameter with the time. 14 -18 For these reasons, the suprarenal segment of the aorta offers great potential as an anchoring site for an endograft. However, until now few data have been available to understand the consequences of suprarenal fixation on renal function.
Malina and colleagues 20 reported a series of 18 patients with AAA who underwent endovascular repair with SF, in which 25 renal arteries ostia were covered by bare metal spring. In a follow-up period of 6 months of media, all renal arteries remained patent without change on renal function assess with serum creatinine level, and only one patient had evidence of a polar infarct at CT scan.
Duda and colleagues 21 performed a SF for AAA in 7 patients with infrarenal neck shorter than 15 mm. In a follow-up period of 10 months of mean, the postoperative CT scan, captopril renography (performed in 5 patients 4 -6 months the procedure), and laboratories analyses showed no renal impairment.
Marin and colleagues 22 observed no significant difference at a mean follow-up of 10 months in SCLs in 2 groups of patients who underwent endograft repair for AAA with infrarenal fixation (n ϭ 16) and SF (n ϭ 35), except for 2 patients, in which a single renal ostia was inadvertently covered by the endograft. At the CT scan, a segmental renal infarction was seen in 2 patients.
MacIerewicz and colleagues 23 compared 19 patients who underwent SF for AAA with 11 patients who underwent infrarenal stent graft fixation. The method of study of renal function was based on RPS 99m TC-DTPA performed preoperatively and postoperatively and on SCL. The immediate postoperative results were communicated but not described because a paper did not follow the abstract of the presentation at the Congress of the Vascular Surgical Society of Great Britain and Ireland. It seems that no significant differences on renal function between the 2 groups were observed.
In Bove and colleagues 24 series 28 patients underwent endovascular repair for AAA using a Talent endograft with SF. No impairment of renal function, assessed by SCL, was observed during a median follow-up period of 6 months except in 1 of the 19 patients with normal preoperative renal function who had a persistently elevated SCL. No renal infarcts were detected at CT scan.
A series by Lobato 25 reported 35 patients with AAA that were treated by Dietrich's team with SF of an endovascular aortic stent graft. In 5 patients, a transient postoperative creatinine level elevation was observed, and no patients developed persistently increased levels of serum creatinine or renal infarct at CT scan. The median follow-up period was of 11 months.
Kichikawa and colleagues 26 evaluated 18 patients who underwent endovascular repair for AAA with SF using a newly designed spiral z-stent endograft. No change on creatinine level was observed except in 1 patient, who developed a bilateral renal artery stenosis 24 hours after the procedure as a result of partial overlapping of the stent-graft fabric. In this patient, a bilateral stenting of the renal artery was required with the postoperative normalization of serum creatinine level. No renal infarct or signs of renal dysfunction were detected during a mean 14-month follow-up.
In a series reported by Izzedine and colleagues, 27 39 patients were treated for AAA with a Gianturco Z stent across renal artery ostia. Renal function was assessed using SCL and creatinine clearance estimated with the Cockcroft-Gault formula and GFR. Two (5%) patients with preoperative RI had an impairment of renal function (GFR Ͼ20%). At 30 months follow-up, renal function remained stable.
In all these article, except for the unpublished data by MacIerewicz, renal function was detected by biochemical tests that are capable mean of analyzing the functional status of the kidneys but are not the ideal tools for a scientific study concerning renal function. In fact, SCL is relatively insensitive, and a large change in renal function must occur before measurement alters significantly. Even if creatinine clearance permits a more accurate method to evaluate GFR, this may be overestimated because of variable tubular secretion of creatinine. 28, 30 Moreover, they test the global renal function but do not give information about function of each kidney. Thus, a direct measurement of GFR is necessary to precisely evaluate renal function. Renal scintigraphy is an accurate method to detect GFR, to evaluate separately the function of the kidneys, and to identify subtle renal functional loss. 28 Duda performed the renography, but unfortunately, only postoperatively. The absence of a preoperative renal scintigraphy does not permit confirmation of a postprocedural renal impairment.
Our study avoids this problem by performing pre-and postoperative serial dosage of SCL and RPS 99m TC-DTPA with the GFR estimate with the Gates method to detect global renal function and to evaluate the function of each kidney. The results of this study confirmed that SCL is not an accurate index to detect renal impairment. In fact, in 3 (6.3%) patients in our series, a significant reduction of GFR (Ͼ20%) was observed in the absence of any relevant change of SCL (patients 1-3, Table 5 ).
Moreover, the RPS 99m TC-DTPA revealed that the impairment of renal function was limited to a single kidney in 2 patients and bilateral in 1 in absence of signs of renal artery stenosis or infarct at the CT scan and at static 99m TC-DTPA scintigraphy (performed in 2 patients). Thereafter, the reduction of the GFR remained stable at the scintigraphic control performed at 1 month and at 1 year (in 1 patient). In these cases microembolism of the renal vascular bed, which is well described during surgical and endovascular procedure of abdominal aorta and renal arteries, appears to be the cause that could explain the permanent renal impairment. 29 CT scan and static 99m TC-DTPA scintigraphy are able to detect areas of infarction Ͼ10 mm in diameter, so this could be the reason why in case of microembolism these exams were negative.
In 2 additional cases (patients 4 and 5 in Table 5 ) a permanent significant reduction (Ͼ20%) of the GFR was observed associated with an increase of SCL Ͼ20%. These were 2 (15.31%) of the 13 patients with preoperative RI. The RPS 99m TC-DTPA showed an impairment of renal function involving, in one case, both kidneys and in the other, only the right. The CT scan did not reveal any area of renal infarct and demonstrated the patency of renal arteries. In these patients the renal damage could be the result of microembolization or acute tubular necrosis secondary to the use of iodine media especially in the patient with GFR reduction involving both kidney. The use of contrast media in patients with RI is nephrotoxic and could play an important role in the worsening of their renal function.
This mechanism of renal toxicity could even explain the transient (reverted within the seventh postoperative day) renal impairment involving both kidney observed in 3 patients of our series with preoperative RI (1 required 3 cycles of dialysis).
Accessory renal arteries occur in 15% to 30% of adult kidneys. Unlike main renal arteries, arising laterally from the aorta, accessory arteries usually originate anteriorly. Blood supply to the kidney is segmental with minor collateral circulation within the renal parenchyma making individual branches functionally terminal arteries. These aberrant vessels can often be detected by preoperative arteriography, spiral CT scanning, or magnetic resonance angiography. When feasible, these vessels are spared during conventional repair of AAA if they are large and supply a distinct segment of the parenchyma. 34 -36 It may be necessary to exclude the origin of some accessory renal arteries when the proximal neck is short or the accessory vessel(s) originate from the aneurysmal sac. Exclusion of these arteries raises the theoretical concern of regional renal ischemia associated with loss of parenchyma or worsening of hypertension. Current recommendations regarding aberrant renal artery exclusion argue against covering these arteries to preserve renal artery perfusion and prevent adverse consequences. [32] [33] [34] We were reluctant to cover any vessel that appeared to perfuse more 25% of the kidney parenchyma. Although current imaging modalities have the ability to delineate most of the vascular renal anomalies encountered during evaluation for endograft repair, they can-not provide a quantitative measurement of the area perfused by the artery. After exclusion accessory renal arteries, the extension of the possible infarction and subsequent clinical sequelae are unknown. However, there are 2 methods that may provide an estimate regarding the size of the expected renal infarction and ultimately determine whether placement of an endograft is appropriate. One method involves nuclear imaging with radionuclide renography, which provides assessment of differential perfusion of the kidneys before the artery in question is killed. The other method was recently reported by Dorffner et al, 34 who uniquely combined selective renal angiography and spiral CT to calculate the volume of renal parenchyma perfused by each artery using a software program provided by the CT manufacturer. Kaplan et al 35 speculate that the low incidence of infarction may be related to poorly understood collateral vascular supply via the renal capsule. Therefore, in some patients, these minor collaterals may provide enough blood flow to prevent infarction in these segmental areas. The difference among these patients lies in the poorly understood collateral circulation surrounding or within the renal parenchyma.
In the recent study published by Aquino 36 et al, hypertension was actually fairly uncommon and transient at worst. One reason for this observation could be the limited amount of renin produced by the small extension of ischemic tissue involved. In our study a Ͻ25% loss of the renal parenchyma was planed as a result of the presence of a renal polar artery in 6 cases and an horseshoe kidney in 1 without any relevant (Ͻ20%) change on GFR.
The exclusion of accessory renal arteries secondary to endograft deployment does not appear to be responsible for renal function impairment if the parenchyma loss is Ͻ25%. 34 The results of our series on renal function are comparable to those reported by the above mentioned studies: 2 (4.2%) cases of permanent impairment of global renal function in patients with preoperative RI and no worsening of global renal function was observed in patients with preoperative normal function. These data are also comparable to those reported by Walker and colleagues 37 in which the incidence of renal impairment was of 6.2% after infrarenal aortic stent-graft implantation performed in 164 patients with normal preoperative renal function.
The causes responsible of the renal function worsening may be ascribed to microembolism, use of iodine dye in patients with preoperative RI and renal flow impairment due to bare springs.
In our opinion, the RPS 99m TC-DTPA is a key test to correctly detect renal function and to localized the impaired kidney, essential endpoints for successful SF of an endovascular graft. In our series, this examination revealed a significant reduction (Ͼ20%) of the GFR in 3 cases without any change on global renal function detected with serum creatinine level.
No graft migration, type I, II, III, IV endoleak, occlusion of renal arteries or aneurysmal sack size increase were observed in the midterm follow-up with a technical success of 91.4 and a clinical success of 95.7%.
The absence of type II endoleak in the midterm followup, is probably not related to the SF of the endograft, but to the presence in 85% of patients of a circumferential thrombus on the aneurysm wall and the consequent absence of lumbar arteries or inferior mesenteric artery originating from the aneurysmal wall.
One high-risk patient (2.1%) died for unknown reasons after 9 months from the procedure. In our series the postoperative CT scan reveal in 24 patients (51.1%), a transvisceral fixation. In 18 cases the uncovered portion of the endograft was placed across the ostium of the superior mesenteric artery and in 5 cases across the celiac artery origin. This was not a surprising result considering the close proximity of these vessels and the stent graft geometry (1.5 cm of proximal uncovered stent for Talent and 2.4 cm for Zenith endograft). During the follow-up, there were not clinical and imaging evidence of occlusion, thromboses or emboli to the visceral vessels, liver or spleen. 38 Because of the small number of patients (n ϭ 47), it was not possible to detect any statistical difference in terms of procedural and renal function results, between the Talent 14 and Zenith 33 endografts. Based on this experience, SF of an aortic endograft can be safely performed with good early and midterm procedural results; with low risk of visceral and clinically significant global renal function impairment, as detected by serum creatinine level. However the risk of GFR impairment (Ͼ20%) detected by RPS 99m TC-DTPA is 10.6%. The risk of global renal function impairment should be taken into consideration in selecting patients undergoing this procedure, especially in those with preoperative RI (Fig. 3) . 
